JEVTANA conc perf 60 mg/1.5ml a solv flac

7680615430015 CH-61543 L01CD04 07.16.1.

Reimbursement limitations:

JEVTANA2

En association avec la prednisone ou la prednisolone, pour le traitement de patients atteints d'un …

JEVTANA conc perf 60 mg/1.5ml a solv flac
JEVTANA conc perf 60 mg/1.5ml a solv flac
JEVTANA conc perf 60 mg/1.5ml a solv flac
1 / 3
google

Details

Product number
6154301
CPT
-
Packaging group
1 + 1
Unit
Durchstechflasche(n)
Composition
cabazitaxelum 60 mg ut cabazitaxeli acetoni solvatum, polysorbatum 80, acidum citricum monohydricum, pro vitro. Solvens: ethanolum 96 per centum 573.3 mg, aqua ad iniectabile ad solutionem pro 4.5 ml.

Articles (1)

Jevtana 60 mg/1.5 ml, solution à diluer et solvant pour solution pour perfusion
Lösung
1 + 1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
22/05/2025
Professional SmPC
Français
22/05/2025
Professional SmPC
Italien
22/05/2025

Detailed composition

Substance Quantity Type Category
SOLV
573.3 MG Substance HBESI
(N/A)
60.0 MG Substance Wirkstoff (Principe actif)
SOLV
- Substance HNIDK
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 2942.05
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2012

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
61543
Drug name
Jevtana, solution à diluer et solvant pour solution pour perfusion
Galenic form
KSINF
ATC Code
L01CD04
Authorization status
Z
Dispensation category
A
First authorization
06/04/2011
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine

Packaging details

Description (FR)
JEVTANA conc perf 60 mg/1.5ml a solv flac
Description (DE)
JEVTANA Inf Konz 60 mg/1.5ml c Solv Durchstf
Market launch
06/04/2011
Narcotic (BTM)
No

Available generics

Cabazitaxel Accord, Konzentrat zur Herstellung einer Infusionslösung
CHF 2690.90
View
Cabazitaxel Labatec, solution à diluer pour perfusion
CHF 2690.90
View
Cabazitaxel Sandoz, Konzentrat zur Herstellung einer Infusionslösung
CHF 2690.90
View
Cabazitaxel Spirig HC, Konzentrat zur Herstellung einer Infusionslösung
CHF 2690.90
View
Cabazitaxel-Teva, Konzentrat zur Herstellung einer Infusionslösung
CHF 2690.90
View
Cabazitaxel Viatris, Konzentrat zur Herstellung einer Infusionslösung
CHF 2690.90
View